Leukotrienes are lipid mediators produced by immune cells that contribute to inflammation, bronchoconstriction, and allergic reactions. Testing is specialized, often in urine or bronchoalveolar lavage, and lacks standardized reference ranges.
Leukotriene is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Leukotriene becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
Leukotriene does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Leukotrienes are a family of eicosanoid inflammatory mediators derived from arachidonic acid via the 5-lipoxygenase pathway. They are primarily produced by mast cells, eosinophils, and other leukocytes and play a central role in the pathogenesis of allergic diseases, asthma, and other inflammatory conditions. Key leukotrienes include LTB4, a potent chemotactic agent for neutrophils, and the cysteinyl leukotrienes (LTC4, LTD4, LTE4), which cause bronchoconstriction, mucus secretion, and vascular permeability.
There is no well-defined 'low' range for leukotrienes, as testing is not standardized and reference values are not established. In general, low or undetectable levels may be seen in healthy individuals without ongoing allergic or inflammatory processes. However, because leukotrienes are produced transiently in response to stimuli, a single low measurement does not rule out episodic conditions. In research, low levels might be observed after effective treatment with leukotriene receptor antagonists or 5-lipoxygenase inhibitors.
Elevated leukotriene levels—when measured—may indicate increased production associated with allergic conditions (e.g., allergic rhinitis, asthma), aspirin-exacerbated respiratory disease, or other inflammatory states. For instance, high urinary LTE4 (LTE4) has been linked to active asthma and may correlate with disease severity. However, because no universal reference range exists, elevation is typically defined relative to population-based median values or clinical context. High levels might also be seen in mastocytosis or other disorders with mast cell activation. Interpretation requires specialist input.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Leukotrienes are typically measured in specialized laboratories using techniques like ELISA or mass spectrometry on urine, blood, or lung fluid. It is not a common lab test and is usually only available in research or specialty clinics.
Leukotriene becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Leukotrienes (LTs) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Leukotrienes are fatty acid-derived signaling molecules made by immune cells. They promote inflammation, attract other immune cells, and can cause narrowing of airways, making them key players in asthma and allergies.
No standard normal range exists because leukotriene tests are not routinely performed and vary by method and specimen type (blood, urine, lavage). Results are interpreted in research or specialized clinical settings, often compared to control values.
A high level may suggest active allergic or inflammatory disease, such as asthma or aspirin sensitivity. However, due to lack of standardization, high is relative to the specific assay and population. Your doctor will explain the findings in your context.
Leukotriene does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Leukotriene is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
